Vizual Stocks works best vertically on mobile.
VizualStocks APIOperating KPI and segment definitions available for Abbvie (ABBV) through the VizualStocks API.
Global net revenue from AbbVie's medical-aesthetics portfolio, led by Botox Cosmetic and the Juvederm collection of dermal fillers.
aestheticsRevenueRevenue from AbbVie products outside the separately reported therapeutic areas during the period.
allOtherRevenueGlobal net revenue from AbbVie's immunology medicines, including Skyrizi, Rinvoq and Humira.
immunologyRevenueRevenue generated outside the United States during the period.
internationalRevenueGlobal net revenue from AbbVie's neuroscience portfolio, including Vraylar, Botox Therapeutic, Ubrelvy, Qulipta and Vyalev.
neuroscienceRevenueGlobal net revenue from AbbVie's cancer-treatment portfolio, including Imbruvica, Venclexta and Elahere.
oncologyRevenueRevenue from AbbVie's other key products outside the separately reported therapeutic areas.
otherKeyProductsRevenueRevenue generated in the United States during the period.
unitedStatesRevenueNet revenue from AbbVie's prescription eye-care portfolio for conditions including glaucoma, retinal disease and dry eye.
eyeCareRevenue